"Rheumatic Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
Descriptor ID |
D012216
|
MeSH Number(s) |
C05.799 C17.300.775
|
Concept/Terms |
Rheumatic Diseases- Rheumatic Diseases
- Disease, Rheumatic
- Diseases, Rheumatic
- Rheumatic Disease
- Rheumatism
|
Below are MeSH descriptors whose meaning is more general than "Rheumatic Diseases".
Below are MeSH descriptors whose meaning is more specific than "Rheumatic Diseases".
This graph shows the total number of publications written about "Rheumatic Diseases" by people in this website by year, and whether "Rheumatic Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 |
1997 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2005 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2009 | 5 | 0 | 5 |
2011 | 4 | 0 | 4 |
2012 | 2 | 1 | 3 |
2013 | 0 | 2 | 2 |
2014 | 0 | 2 | 2 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 2 | 1 | 3 |
2018 | 1 | 0 | 1 |
2019 | 5 | 0 | 5 |
2020 | 1 | 0 | 1 |
2021 | 2 | 0 | 2 |
2022 | 2 | 0 | 2 |
2023 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rheumatic Diseases" by people in Profiles.
-
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments. Semin Arthritis Rheum. 2024 Apr; 65:152344.
-
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases. RMD Open. 2023 10; 9(4).
-
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken). 2023 03; 75(3):449-464.
-
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group. Semin Arthritis Rheum. 2023 02; 58:152110.
-
Targeting Multiple End Organs in Lupus and Other Systemic Rheumatic Diseases by Inhibiting Bruton's Tyrosine Kinase. Front Immunol. 2022; 13:893899.
-
Osteoporotic Fractures and Vertebral Body Reshaping in Children With Glucocorticoid-treated Rheumatic Disorders. J Clin Endocrinol Metab. 2021 11 19; 106(12):e5195-e5207.
-
Reintroduction of immunosuppressive medications in pediatric rheumatology patients with histoplasmosis: a case series. Pediatr Rheumatol Online J. 2021 Jun 07; 19(1):84.
-
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors. Support Care Cancer. 2020 Dec; 28(12):6159-6173.
-
Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy. Rheumatology (Oxford). 2019 12 01; 58(Suppl 7):vii40-vii48.
-
Curcumin in Autoimmune and Rheumatic Diseases. Nutrients. 2019 May 02; 11(5).